Health and Human Services Secretary Robert F. Kennedy Jr. said during a news conference on Wednesday that “we’re cutting unnecessary red tape, reducing uncertainty and making it easier for innovators to bring the safe, affordable biosimilars to the market.” (ALEX BRANDON/AP)
HHS Secretary Robert F. Kennedy Jr. is facing a coordinated takedown effort by the same establishment he has threatened to expose, writes Armstrong Williams.